Daniel Feger
Impact in
- Biotechnology top 10%
- Marine Sponges and Natural Products
- Pharmacology top 10%
- Microbial Natural Products and Biosynthesis
- Fungal Biology and Applications
Papers in
-
- Ion Transport and Channel Regulation 1
- Histone Deacetylase Inhibitors Research 1
- Oncology 3
- Cancer Treatment and Pharmacology 2
- Co-authors
- Amal H. Aly (2 shared papers)Peter Proksch (2 shared papers)Wenhan Lin (2 shared papers)Anthoula Gaigneaux (1 shared paper)Karsten Siems (1 shared paper)Daowan Lai (1 shared paper)Carole Seidel (1 shared paper)Michaël Schnekenburger (1 shared paper)
- Journals
- Journal of Natural Products (2 papers)Cancer Research (2 papers)Chemie Ingenieur Technik (1 paper)SLAS DISCOVERY (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)
- Partner nations
- GermanyChinaNetherlands
In The Last Decade
Daniel Feger
9 papers receiving 172 citations
Peers
Comparison fields: 5 of 46
- Biotechnology 52
- Pharmacology 84
- Toxicology 13
- Organic Chemistry 64
- Cancer Research 20
Countries citing papers authored by Daniel Feger
This map shows the geographic impact of Daniel Feger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Feger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Feger more than expected).
Fields of papers citing papers by Daniel Feger
This network shows the impact of papers produced by Daniel Feger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Feger. The network helps show where Daniel Feger may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Feger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 100 | |
| 2 | 2014 | 56 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 3 | |
| 5 | 2019 | 3 | |
| 6 | 2014 | 2 | |
| 7 | 2022 | 2 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 1 |
About Daniel Feger
Daniel Feger is a scholar working on Molecular Biology, Oncology, Pharmacology, Biophysics and Biomedical Engineering, having authored 9 papers that have together received 173 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (2 papers), Spectroscopy Techniques in Biomedical and Chemical Research (2 papers), Microfluidic and Capillary Electrophoresis Applications (2 papers), Innovative Microfluidic and Catalytic Techniques Innovation (2 papers), Ion Transport and Channel Regulation (1 paper), Synthesis and Biological Activity (1 paper), Bioactive Compounds and Antitumor Agents (1 paper) and Histone Deacetylase Inhibitors Research (1 paper). The work is most often cited by research in Biotechnology (52 citations), Pharmacology (84 citations), Toxicology (13 citations), Organic Chemistry (64 citations) and Cancer Research (20 citations). Daniel Feger has collaborated with scholars based in Germany, China and Netherlands. Frequent co-authors include Amal H. Aly, Peter Proksch, Wenhan Lin, Anthoula Gaigneaux, Karsten Siems, Daowan Lai, Carole Seidel, Michaël Schnekenburger, Marc Diederich and Abdessamad Debbab. Their work appears in journals such as Journal of Natural Products, Cancer Research, Chemie Ingenieur Technik, SLAS DISCOVERY and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.